The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis
Open accessAbstract
Atherosclerosis is a chronic inflammatory disease promoted by hyperlipidemia. Several studies support FOXP3-positive regulatory T cells (Tregs) as inhibitors of atherosclerosis; however, the mechanism underlying this protection remains elusive. To define the role of FOXP3-expressing Tregs in atherosclerosis, we used the DEREG mouse, which expresses the diphtheria toxin (DT) receptor under control of the Treg-specific Foxp3 promoter, allowing for specific ablation of FOXP3+ Tregs. Lethally irradiated, atherosclerosis-prone, low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice received DEREG bone marrow and were injected with DT to eliminate FOXP3(+) Tregs. Depletion of Tregs caused a 2.1-fold increase in atherosclerosis without a concomitant increase in vascular inflammation. These mice also exhibited a 1.7-fold increase in plasma cholesterol and an atherogenic lipoprotein profile with increased levels of VLDL. Clearance of VLDL and chylomicron remnants was hampered, leading to accumulation of cholesterol-rich particles in the circulation. Functional and protein analyses complemented by gene expression array identified reduced protein expression of sortilin-1 in liver and increased plasma enzyme activity of lipoprotein lipase, hepatic lipase, and phospholipid transfer protein as mediators of the altered lipid phenotype. These results demonstrate that FOXP3(+) Tregs inhibit atherosclerosis by modulating lipoprotein metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Self-citationControl of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187 · cited 1×
“The forkhead box transcription factor, FOXP3, was identified as the key lineage marker and master switch in the regulation of Treg development and function (10–12).”
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608 · cited 1×
“Tregs were initially characterized as CD4+CD25+ T cells that could suppress the activity of effector T cells (8).”
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Self-citationThe immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Self-citationTabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Swirski, F. K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R., & Pittet, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29950 · Cited by 1,148
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus
Musunuru, K., Strong, A., Frank-Kamenetsky, M., Lee, N. E., Ahfeldt, T., Sachs, K. V., Li, X., Li, H., Kuperwasser, N., Ruda, V. M., et al. (2010) · Nature · doi:10.1038/nature09266 · Cited by 1,140
Natural regulatory T cells control the development of atherosclerosis in mice
Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A.-K. L., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., et al. (2006) · Nature Medicine · doi:10.1038/nm1343 · Cited by 1,100
Self-citationSelective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease
Lahl, K., Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G., Hamann, A., Wagner, H., Huehn, J., & Sparwasser, T. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061852 · Cited by 924
Self-citationProtective Role of Interleukin-10 in Atherosclerosis
Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M. F., Soubrier, F., Esposito, B., Duez, H., Fievet, C., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.8.e17 · Cited by 831
From Vanilla to 28 Flavors: Multiple Varieties of T Regulatory Cells
Shevach, E. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.003 · Cited by 549
Disruption of TGF-β signaling in T cells accelerates atherosclerosis
Robertson, A.-K. L., Rudling, M., Zhou, X., Gorelik, L., Flavell, R. A., & Hansson, G. K. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18607 · Cited by 441
Self-citationJiang, X.-C., Bruce, C., Mar, J., Lin, M., Ji, Y., Francone, O. L., & Tall, A. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5578 · Cited by 394
Pinderski, L. J., Fischbein, M. P., Subbanagounder, G., Fishbein, M. C., Kubo, N., Cheroutre, H., Curtiss, L. K., Berliner, J. A., & Boisvert, W. A. (2002) · Circulation Research · doi:10.1161/01.res.0000018941.10726.fa · Cited by 356
Role of Naturally Occurring CD4 + CD25 + Regulatory T Cells in Experimental Atherosclerosis
Mor, A., Planer, D., Luboshits, G., Afek, A., Metzger, S., Chajek-Shaul, T., Keren, G., & George, J. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000259365.31469.89 · Cited by 348
McHugh, R. S., & Shevach, E. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.5979 · Cited by 319
Mallat, Z., Gojova, A., Brun, V., Esposito, B., Fournier, N., Cottrez, F., Tedgui, A., & Groux, H. (2003) · Circulation · doi:10.1161/01.cir.0000089083.61317.a1 · Cited by 306
Merkel, M., Loeffler, B., Kluger, M., Fabig, N., Geppert, G., Pennacchio, L. A., Laatsch, A., & Heeren, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411412200 · Cited by 291
Stoneman, V., Braganza, D., Figg, N., Mercer, J., Lang, R., Goddard, M., & Bennett, M. (2007) · Circulation Research · doi:10.1161/01.res.0000260802.75766.00 · Cited by 261
Jiang, X.-C., Qin, S., Qiao, C., Kawano, K., Lin, M., Skold, A., Xiao, X., & Tall, A. R. (2001) · Nature Medicine · doi:10.1038/89977 · Cited by 256
Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis
Hermansson, A., Ketelhuth, D. F. J., Strodthoff, D., Wurm, M., Hansson, E. M., Nicoletti, A., Paulsson-Berne, G., & Hansson, G. K. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092243 · Cited by 240
Self-citationHepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism
Strong, A., Ding, Q., Edmondson, A. C., Millar, J. S., Sachs, K. V., Li, X., Kumaravel, A., Wang, M. Y., Ai, D., Guo, L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63563 · Cited by 222
Gotsman, I., Grabie, N., Gupta, R., Dacosta, R., MacConmara, M., Lederer, J., Sukhova, G., Witztum, J. L., Sharpe, A. H., & Lichtman, A. H. (2006) · Circulation · doi:10.1161/circulationaha.106.633263 · Cited by 215
Klingenberg, R., Lebens, M., Hermansson, A., Fredrikson, G. N., Strodthoff, D., Rudling, M., Ketelhuth, D. F. J., Gerdes, N., Holmgren, J., Nilsson, J., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.202671 · Cited by 201
Self-citationTreating inflammation in atherosclerotic cardiovascular disease: emerging therapies
Klingenberg, R., & Hansson, G. K. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp477 · Cited by 169
Self-citationGojová, A., Brun, V., Esposito, B., Cottrez, F., Gourdy, P., Ardouin, P., Tedgui, A., Mallat, Z., & Groux, H. (2003) · Blood · doi:10.1182/blood-2003-05-1729 · Cited by 150
Lymphotoxin ß Receptor–Dependent Control of Lipid Homeostasis
Lo, J. C., Wang, Y., Tumanov, A. V., Bamji, M., Yao, Z., Reardon, C. A., Getz, G. S., & Fu, Y. (2007) · Science · doi:10.1126/science.1137221 · Cited by 142
Parini, P., Johansson, L., Bröijersén, A., Angelin, B., & Rudling, M. J. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01597.x · Cited by 128
Self-citation[32] Phospholipase activity of milk lipoprotein lipase
Bengtsson-Olivecrona, G., & Olivecrona, T. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)97160-z · Cited by 124
Bergö, M. O., Olivecrona, G., & Olivecrona, T. (1996) · Biochemical Journal · doi:10.1042/bj3130893 · Cited by 121
Self-citationTaguchi, O., & Takahashi, T. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260730 · Cited by 97
Mechanisms of Disease: the evolving role of regulatory T cells in atherosclerosis
George, J. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1279 · Cited by 82
VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice
VanderLaan, P. A., Reardon, C. A., Thisted, R. A., & Getz, G. S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800284-jlr200 · Cited by 67
Klingenberg, R., Nofer, J., Rudling, M., Bea, F., Blessing, E., Preusch, M. R., Gröne, H. ‐., Katus, H. A., Hansson, G. K., & Dengler, T. J. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149476 · Cited by 64
Self-citationDetermination of human plasma phospholipid transfer protein mass and activity
Jauhiainen, M., & Ehnholm, C. (2005) · Methods · doi:10.1016/j.ymeth.2004.11.006 · Cited by 61
Self-citationGroyer, É., Nicoletti, A., Ait‐Oufella, H., Khallou‐Laschet, J., Varthaman, A., Gaston, A., Thaunat, O., Kaveri, S. V., Blatný, R., Stockinger, H. S. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.040 · Cited by 41
Samyn, H., Moerland, M., van Gent, T., van Haperen, R., Grosveld, F. G., van Tol, A., & de Crom, R. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.10.020 · Cited by 40
Flow-cytometric determination of high-density-lipoprotein binding sites on human leukocytes.
Schmitz, G., Wulf, G. M., Brüning, T., & Assmann, G. (1987) · Clinical Chemistry · doi:10.1093/clinchem/33.12.2195 · Cited by 34
Acute Elevation of Plasma PLTP Activity Strongly Increases Pre-existing Atherosclerosis
Moerland, M., Samyn, H., van Gent, T., van Haperen, R., Dallinga‐Thie, G. M., Grosveld, F. G., van Tol, A., & de Crom, R. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.165084 · Cited by 32
Nutritional regulation of lipoprotein lipase in mice
Ruge, T., Wu, G., Olivecrona, T., & Olivecrona, G. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00256-5 · Cited by 31
Self-citationvan Haperen, R., Samyn, H., Moerland, M., van Gent, T., Peeters, M. C. E., Grosveld, F. G., van Tol, A., & de Crom, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002255 · Cited by 27
Conversion of chylomicrons into remnants
Hultin, M., & Olivecrona, T. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00229-9 · Cited by 23
Samyn, H., Moerland, M., van Gent, T., van Haperen, R., Metso, J., Grosveld, F. G., Jauhiainen, M., van Tol, A., & de Crom, R. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800080-jlr200 · Cited by 17
Self-citationEffect of protamine on lipoprotein lipase and hepatic lipase in rats
Hultin, M., Olivecrona, G., & Olivecrona, T. (1994) · Biochemical Journal · doi:10.1042/bj3040959 · Cited by 15
Self-citationOptimal Isolation of Functional Foxp3+ Induced Regulatory T Cells Using DEREG Mice
Baru, A. M., Untucht, C., Ganesh, V., Hesse, C., Mayer, C. T., & Sparwasser, T. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044760 · Cited by 10
Self-citation
Cited by
Immunity and Inflammation in Atherosclerosis
Wolf, D., & Ley, K. (2019) · Circulation Research · doi:10.1161/circresaha.118.313591 · Cited by 1,697
The immunology of atherosclerosis
Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982
Self-citationShort-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage
Bartolomaeus, H., Balogh, A., Yakoub, M., Homann, S., Markó, L., Höges, S., Tsvetkov, D., Krannich, A., Wundersitz, S., Avery, E. G., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036652 · Cited by 815
Inflammation and plaque vulnerability
Hansson, G. K., Libby, P., & Tabas, I. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12406 · Cited by 805
Self-citationT cell subsets and functions in atherosclerosis
Saigusa, R., Winkels, H., & Ley, K. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0352-5 · Cited by 721
Metadata
- Authors
- Klingenberg, R., Gerdes, N., Badeau, R. M., Gisterå, A., Strodthoff, D., Ketelhuth, D. F. J., Lundberg, A. M., Rudling, M., Nilsson, S. K., Olivecrona, G., Zoller, S., Lohmann, C., Lüscher, T. F., Jauhiainen, M., Sparwasser, T., & Hansson, G. K.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-02-15
- Volume
- 123
- Issue
- 3
- Pages
- 1323-1334
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2027516092
- Cited by
- 367
- References
- 51
- FWCI
- 18.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.